Literature DB >> 33214678

ATR-FTIR spectroscopy in blood plasma combined with multivariate analysis to detect HIV infection in pregnant women.

Lidiane G Silva1, Ana F S Péres2,3, Daniel L D Freitas1, Camilo L M Morais4, Francis L Martin5, Janaina C O Crispim2,3, Kassio M G Lima6.   

Abstract

The primary concern for HIV-infected pregnant women is the vertical transmission that can occur during pregnancy, in the intrauterine period, during labour or even breastfeeding. The risk of vertical transmission can be reduced by early diagnosis. Therefore, it is necessary to develop new methods to detect this virus in a quick and low-cost fashion, as colorimetric assays for HIV detection tend to be laborious and costly. Herein, attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy combined with multivariate analysis was employed to distinguish HIV-infected patients from healthy uninfected controls in a total of 120 blood plasma samples. The best sensitivity (83%) and specificity (92%) values were obtained using the genetic algorithm with linear discriminant analysis (GA-LDA). These good classification results in addition to the potential for high analytical frequency, the low cost and reagent-free nature of this method demonstrate its potential as an alternative tool for HIV screening during pregnancy.

Entities:  

Mesh:

Year:  2020        PMID: 33214678      PMCID: PMC7677535          DOI: 10.1038/s41598-020-77378-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

The human immunodeficiency virus (HIV) is the cause of a sexually transmitted infection that compromises the immunological system. This virus, belonging to the Lentiviridae family, attacks the cells of the immunological system, especially the T lymphocyte CD4 + cells, making them vulnerable to other infections[1]. The decrease of T lymphocytes CD4 + cells by HIV is one of the main causes of AIDS (acquired immune deficiency syndrome)[2]. HIV was first identified in the 1980′s and since then it has affected millions of people, becoming a major public health problem[3]. Worldwide, around 38 million people are infected with HIV, from which 1.8 million are children and 35 million are adults[4]. According to the epidemiological bulletin from the Brazilian Ministry of Health[5], 116,292 cases of gestational HIV were diagnosed in Brazil between 2000 and 2018, from which 7,888 cases were recorded in 2017. One of the main concerns for HIV-infected pregnant women is the viral transmission from the mother to the child[3]. This is termed vertical transmission and can occur during pregnancy (intrauterine), during labour or during breastfeeding. The risk of vertical transmission can be reduced by early diagnosis whereupon antiretroviral treatment can be implemented to reduce viral load. Early HIV diagnosis has increased 21% in the last 10 years, enabling adequate treatment for women during pregnancy, thus improving their quality of life and reducing the risk of vertical transmission. Between 2007 and 2017, prenatal diagnosis resulted in an increase from 2.3 cases per thousand live births to 2.8 cases per thousand live births[5]. The diagnosis of gestational HIV can be made in blood using immunoassays such as immunochromatography (a rapid test) or the ELISA (enzyme-linked immunosorbent assay) test, which enables one to score both antibodies and antigens. The viral load in HIV-infected patients are estimated > 1,000–1,500 copies/mL[6,7]. Colorimetric assays to detect HIV have a high-cost and require labour-intensive procedures, since each metabolite is detected one at a time[8]. Spectrometric techniques have been used as metabolomic tools to discriminate biofluids derived from infected vs. healthy patients. Mass spectrometry (MS) and nuclear magnetic resonance (NMR) are the most widely used techniques. Although having high sensitivity and specificity, these techniques have a high-cost and detailed sample preparation is often required[2]. Attenuated total reflection Fourier-transform infrared (ATR-FITR) spectroscopy is a fast, low-cost, non-destructive and reagent-free alternative to these spectrometric techniques, being able to generate a fingerprint spectrum containing both structural and concentration information for the constituent metabolites in the sample[9]. There remain a limited number of applications using ATR-FTIR spectroscopy to detect HIV-infected samples. Sitole et al.[8] showed for the first time metabolic differences between healthy uninfected and infected groups using ATR-FTIR spectroscopy where chemometric tools were employed to distinguish healthy uninfected vs. HIV-infected patients, in addition to distinguishing infected patients with or without antiretroviral treatment. Herein, ATR-FTIR spectroscopy combined with multivariate analysis is used to discriminate healthy uninfected and HIV-infected pregnant women based on their blood plasma spectra. Different chemometric techniques were tested, including approaches based on principal component analysis (PCA), successive projections algorithm (SPA) and genetic algorithm (GA).

Results

The infrared (IR) spectra of blood plasma for control (healthy uninfected pregnant women) and HIV-infected pregnant women are shown in Fig. 1A. A total of 120 samples were analysed, generating 360 spectra (3 spectra per sample). The 3 spectra per sample were averaged before model construction. The sample set was composed of 80 healthy uninfected controls and 40 HIV-infected samples. Study participant information and demographics is shown in Table 1.
Figure 1

Infrared (IR) spectra. (A) Mean raw IR spectra in the bio-fingerprint region (1800–900 cm−1) for HIV-infected (HIV) and healthy uninfected controls (HC) samples. (B) Mean pre-processed IR spectra (AWLS baseline correction) in the bio-fingerprint region (1800–900 cm−1) for HIV-infected (HIV) and healthy uninfected controls (HC) samples.

Table 1

Study participant information and demographics.

Group
Case (HIV-infection)Control uninfected
Age (mean ± SD)28 ± 631 ± 6
Gestational age (weeks ± SD)21 ± 724 ± 7
Smoking, n (%)
Yes4 (10.3%)0
No35 (89.7%)35 (100%)
Drugs use, n (%)
Yes7 (18%)3 (8.57%)
No32 (82%)33 (94.3%)
Infrared (IR) spectra. (A) Mean raw IR spectra in the bio-fingerprint region (1800–900 cm−1) for HIV-infected (HIV) and healthy uninfected controls (HC) samples. (B) Mean pre-processed IR spectra (AWLS baseline correction) in the bio-fingerprint region (1800–900 cm−1) for HIV-infected (HIV) and healthy uninfected controls (HC) samples. Study participant information and demographics. In the region between 1800 to 900 cm−1 (bio-fingerprint region), the spectra show characteristic absorptions: Amide I band at 1635 cm−1 [10], an arm at 1560 cm−1 (C = O, Amide II)[11] and three small intensity absorptions at 1480 cm−1 (C-H asymmetric deformation of methyl groups), 1404 cm−1 (COO − symmetric stretching of proteins and lipids) and 1060 cm−1 (C-O nucleic acids)[10]. To correct for baseline distortions, the raw spectral data were pre-processed by automatic weighted least squares (AWLS) baseline correction (Fig. 1B). Due to the high similarity between the spectral features for both groups (control uninfected and HIV infected), chemometric approaches were employed to identify spectral features responsible for class differentiation. PCA with linear discriminant analysis (PCA-LDA), quadratic discriminant analysis (PCA-QDA) or support vector machines (PCA-SVM); successive projections algorithm with linear discriminant analysis (SPA-LDA), quadratic discriminant analysis (SPA-QDA) or support vector machines (SPA-SVM); and, genetic algorithm with linear discriminant analysis (GA-LDA), quadratic discriminant analysis (GA-QDA) or support vector machines (GA-SVM) were tested as feature extraction/selection and classification tools. The performance for each algorithm tested was evaluated by calculating the accuracy, sensitivity, specificity, F-score and G-score for the test set. Both classes were separated into training (70%) and test (30%) sets using the Kennard-Stone algorithm[12], whereby the training set was used for model construction and the test set for model validation. The classification metrics in the test set for each algorithm is shown in Table 2.
Table 2

Quality parameters calculated in the test set to classify healthy uninfected controls vs. HIV-infected samples.

ModelACSENSSPECF-ScoreG-Score
PCA-LDA7067716969
PCA-QDA5883465962
PCA-SVM8183798181
SPA-LDA7550886466
SPA-QDA648921528
SPA-SVM678961587
GA-LDA8983928787
GA-QDA6481001529
GA-SVM66.7010000

AC = accuracy, SENS = sensitivity, SPEC = specificity.

Quality parameters calculated in the test set to classify healthy uninfected controls vs. HIV-infected samples. AC = accuracy, SENS = sensitivity, SPEC = specificity. From all models tested, the best classification performances were obtained by PCA-SVM, SPA-LDA and GA-LDA. PCA-SVM showed a good accuracy (81%) and sensitivity (83%), but the specificity was < 80% (79%) in the test. SPA-LDA selected 22 spectral wavenumbers for class differentiation, generating a good specificity (88%), but poor accuracy (75%) and sensitivity (50%). GA-LDA was the best classification algorithm, with an accuracy of 89%, and sensitivity and specificity of 83% and 92%, respectively. The F-score (87%) and G-score (87%) show consistency, indicating that the classification performance was not affected by imbalanced class sizes. GA-LDA selected 4 spectral wavenumbers, among the 467 in the entire bio-fingerprint spectral range, for class differentiation. These wavenumbers were: 1653, 1558, 1506 and 901 cm−1 (Fig. 2A). The GA-LDA discriminant function (DF) in the test set is depicted in Fig. 2B, while the tentative biomarkers assignment[9] for the 4 selected wavenumbers are shown in Table 3.
Figure 2

GA-LDA results. (A) Selected wavenumbers (901, 1506, 1558, 1653 cm−1) responsible for class separation. (B) Discriminant function (DF) for the samples in the test set, where HIV stands for HIV-infected samples and HC for healthy uninfected controls.

Table 3

Wavenumbers selected by GA-LDA to discriminate healthy uninfected controls vs. HIV-infected samples.

Selected wavenumber (cm−1)Tentative assignment
901Phosphodiester stretching
1506Ring base
1558Amide II (N–H bending vibration)
1653Amide I (C = O stretching)

Tentative assignment based on Movasaghi et al.[10].

GA-LDA results. (A) Selected wavenumbers (901, 1506, 1558, 1653 cm−1) responsible for class separation. (B) Discriminant function (DF) for the samples in the test set, where HIV stands for HIV-infected samples and HC for healthy uninfected controls. Wavenumbers selected by GA-LDA to discriminate healthy uninfected controls vs. HIV-infected samples. Tentative assignment based on Movasaghi et al.[10].

Discussion

HIV infection remains a major cause of morbidity and mortality worldwide[13], being mainly transmitted during unprotected sexual intercourse, as well as by the sharing of infected needles or syringes, blood transfusion, and by mother-to-child transmission during pregnancy, labour or breastfeeding[14]. This latter phenomenon is termed vertical transmission and is the focus of this study. The vertical transmission rate ranges from 15 to 45% worldwide, although this figure can be reduced to < 5% if effective intervention measures are applied. Early diagnosis and correct treatment with anti-retrovirals are among these measures[15]. In Brazil, a considerable proportion of HIV diagnosis for the female population occurs during pregnancy, where diagnosis via an anti-HIV serological screening is performed[15]. This reflects the adequacy of the health policy in prenatal care, although conscientisation campaigns on measures to prevent sexually transmitted infections and unintended pregnancy must still be disseminated widely to improve population health[16]. Early diagnosis is of fundamental importance towards maintaining both the mother’s and new-born’s health with the intention of reducing vertical transmission risks. Diagnoses are commonly performed by screening using immunoassays; that is, tests that seek for the presence of anti-HIV antibodies and/or antigen p24 (protein in the virus nucleocapsid). These tests normally have high sensitivity and specificity, and are available in rapid-test formats (e.g., immunochromatography), where the result is obtained within 30 min, or in the ELISA format[17]. Despite these advantages, current biochemical tests require skilled technicians, the use of unstable reagents highly dependent on storage conditions, and production of biochemical waste. Using these approaches, there is a possibility of HIV detection after 2 to 3 weeks from initial viral exposure. There are other more complex tests generally used as complementary and/or confirmatory tests when screening tests diverge, such as the Western Blot, Imunoblot, Fast Imunoblot and molecular biology testing[18], although these tests have a substantially higher cost and require highly-skilled labour and specialist facilities. Molecular biology testing is of fundamental importance for early diagnosis, since it is capable of identifying the virus’ presence before the period of production of immunoglobulins through the amplification of viral nucleic acids. ATR-FTIR spectroscopy is capable of detecting metabolic changes after viral infection[19], and has been successfully used to identify a range of viruses, such as Zika, Dengue and Chikungunya[20,21]. Herein, ATR-FTIR spectroscopy harnessed to chemometric techniques was employed to detect HIV infection in pregnant women. The spectral information responsible for class differentiation is probably associated with metabolic changes caused by the viral infection. Since the samples were measured in liquid state, water is a possible interference that may compress and mask some of the absorption bands, altering their profiles in comparison with dessicated samples. Water mainly affects the high-region of the IR spectrum, with strong bands at 3,300–3,400 cm−1 (hydrogen-bonded O–H stretching) and 3,600–3,650 cm−1 (free O–H stretching)[22]. Since, we worked with the bio-fingerprint region (900–1,800 cm−1) only, these main water bands were removed. However, water has an absorbance band within the bio-fingerprint region at 1646 cm−1, which broadens the Amide I band and creates a shoulder[23]. In addition, absorbances < 1,000 cm−1 tend to greatly increase in a liquid environment, hence, compressing the bands between 1,200–1,500 cm−1 [23]. The virus identification was successfully performed on 40 HIV-infected samples vs. 80 healthy controls using GA-LDA algorithm, with a classification accuracy of 89%. For details, see Supporting information. Four spectral wavenumbers were responsible for class separation based on GA-LDA (Table 2): these included phosphodiester stretching bands at 901 cm−1, 1506 cm−1 (Ring base), protein bands at 1653 cm−1 (Amide I) and 1558 cm−1 (Amide II). The sample discrimination caused by changes in these protein features can be justified by the increase of immunoglobulin levels to fight the infection, since when viral infection happens, the immunological system is hyper-activated, hence, increasing production of immunoglobulin[13]. Sitole et al.[8] using ATR-FTIR spectroscopy also assigned the observed spectral changes between uninfected controls and HIV-infected patients to spectral regions associated with lipids, carbohydrates and proteins. Some protein wavenumbers responsible for class discrimination were: 1652 and 1650 cm−1 (Amide I) and 1500 and 1504 cm−1 (Amide II). Herein, ATR-FTIR spectroscopy with multivariate analysis was able to accurately predict HIV-infected pregnant women based on blood plasma, showing the potential of this method for early detection of HIV in a fast and reagent-free approach. Successful development of this method in a clinical environment could aid early diagnosis of gestational HIV and help treatment.

Methods

Samples

This study was approved by the ethics committee at the Maternidade Escola Januário Cicco (MEJC) from the Federal University of Rio Grande do Norte with the protocol number 1.808.891 and informed consent was obtained from all subjects. Also, all the methods carried out in this study were by the approved guidelines. The patients were selected according to the automatic request that they underwent prenatal appointments, where the patients were asked whether they were willing to participate in this study. If accepted, an Informed Consent Form was read and signed by the participants. The participants answered a questionnaire and some clinical details were obtained from their medical records after consent. The inclusion criteria were: pregnant women between 12 to 30 weeks of pregnancy (Table 1), with or without HIV diagnosed and undergoing prenatal care. Forty blood plasma samples (n = 40) were collected from HIV-positive patients (HIV-infected group) and eighty blood plasma samples (n = 80) from healthy uninfected controls. The samples were collected from May 2017 to March 2019 from patients attending the Maternidade Escola Januário Cicco (MEJC) and the Centro Reprodutivo Dra. Leide Morais in Natal/Brazil. Blood samples were collected into EDTA tubes and, thereafter, centrifuged for 10 min at 1500 rpm at room temperature to separate the blood plasma.

Spectral acquisition

An FTIR IR-Affinity-1S spectrometer (Shimadzu Corporation, Japan) was used for spectral acquisition attached to an ATR accessory containing a diamond crystal as reflector element. The instrument was setup to run 32 scans per sample with a spectral resolution of 4 cm−1. Measurements were carried out in triplicate. The IR spectra were recorded between 4000 to 600 cm−1 using 10 µL of sample directly applied onto the ATR crystal. Before starting the measurements, the ATR crystal was cleaned with ethanol 70% v/v and acetone; and before each new sample, the ATR crystal was cleaned with ethanol 70% v/v. A background spectrum was taken before measuring every new sample to account for environmental changes.

Data analysis

The spectral data analysis was performed within MATLAB R2014b environment (MathWorks, Inc., USA) using the PLS-Toolbox version 7.9.3 and lab-made routines. The data were pre-processed by automatic weighted least squares (AWLS) baseline correction and organised so that the samples were split into training (70%) and test (30%) sets using the Kennard-Stone uniform sampling algorithm[12]. The following feature extraction/selection and classification algorithms were tested to discriminate healthy controls vs. HIV-infected samples: principal component analysis with linear discriminant analysis (PCA-LDA), quadratic discriminant analysis (PCA-QDA) and support vector machines (PCA-SVM); successive projections algorithm with linear discriminant analysis (SPA-LDA), quadratic discriminant analysis (SPA-QDA) and support vector machines (SPA-SVM); and genetic algorithm with linear discriminant analysis (GA-LDA), quadratic discriminant analysis (GA-QDA) and support vector machines (GA-SVM). In PCA-LDA/QDA/SVM, the principal component analysis (PCA) scores[24] are used as input variables for linear discriminant analysis (LDA), quadratic discriminant analysis (QDA) or support vector machines (SVM)[25,26]. The successive projections algorithm (SPA)[27] and the genetic algorithm (GA)[28] are feature selection algorithms, where the first works by selecting spectral wavenumbers that minimises the data collinearity, and the latter selecting spectral wavenumbers according to an evolution-based process, where sets of wavenumbers undergo combinations, crossover and mutations until a fitting criterion is reached, which is the minimisation of the following cost-function [29]: where is the number of validation samples, and is defined as:where the numerator is the squared Mahalanobis distance between object of class index and the sample mean of its true class; and the denominator is the squared Mahalanobis distance between object and the center of the closest wrong class. GA was performed using 100 generations with 200 chromosomes each, with a mutation and crossover probability of 10% and 60%, respectively. LDA, QDA and SVM were used as classification techniques coupled SPA and GA selected variables. LDA and QDA are discriminant analysis algorithms based on a Mahalanobis distance calculation between the samples. The main difference between them is that LDA assumes classes having similar variance structures, by using a pooled covariance matrix, while QDA assumes classes having different variance structures by using the variance–covariance matrix of each class individually for calculation[25]. The LDA classification score for sample of class () is calculated in a non-Bayesian as follow[25,30]:where is a vector with the input variables for sample ; is the mean of class ; and is the pooled covariance matrix between the classes. The QDA classification score for sample of class () is estimated using the variance–covariance for each class () in a non-Bayesian form as follows[25,30]: SVM is a binary linear classifier using a nonlinear step that transforms the input sample space into a feature space using a kernel function that maximizes the margins of separation between the sample groups[31]. In this study, a radial basis function (RBF) kernel was used since it is able to adapt to different data distributions[32]. The SVM classification rule is obtained by the following Eq. [26]:where is the number of support vectors; is the Lagrange multiplier; is the class membership ( 1); is the kernel function; and is the bias parameter. These SVM parameters were obtained and optimized via cross-validation.

Quality performance

The accuracy, sensitivity, specificity, F-Score and G-Score were calculated in the test set to evaluate the models classification performances. The accuracy represents the total number of samples correctly classified considering true and false negatives, the sensitivity represents the proportion of positive samples (i.e., HIV-infected) correctly classified, the specificity represents the proportion of negative samples (i.e., healthy uninfected controls) correctly classified, the F-score measures the overall classification performance considering imbalanced data, and the G-score measures the overall classification performance not accounting for class sizes[33]. The equations to calculate these parameters are shown in Table 4.
Table 4

Equations to calculate the classification quality parameters.

ParameterEquation
Accuracy (AC) (%)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\left( {\frac{{{\text{TP}} + {\text{TN}}}}{{{\text{TP}} + {\text{FP}} + {\text{TN}} + {\text{FN}}}}} \right){\text{ x }}100$$\end{document}TP+TNTP+FP+TN+FNx100
Sensitivity (SENS) (%)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\left( {\frac{{{\text{TP}}}}{{{\text{TP}} + {\text{FN}}}}} \right){\text{x }}100$$\end{document}TPTP+FNx100
Specificity (SPEC) (%)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\left( {\frac{{{\text{TN}}}}{{{\text{TN}} + {\text{FP}}}}} \right){\text{ x }}100$$\end{document}TNTN+FPx100
F-Score (%)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\left( {\frac{{2{ } \times {\text{ SENS }} \times {\text{ SPEC}}}}{{{\text{SENS}} + {\text{SPEC}}}}} \right)$$\end{document}2×SENS×SPECSENS+SPEC
G-Score (%)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sqrt {{\text{SENS }} \times {\text{ SPEC}}}$$\end{document}SENS×SPEC

TP stands for true positive, TN for true negative, FP for false positive and FN for false negative.

Equations to calculate the classification quality parameters. TP stands for true positive, TN for true negative, FP for false positive and FN for false negative. Supplementary Information.
  11 in total

Review 1.  Infrared spectroscopy of proteins.

Authors:  Andreas Barth
Journal:  Biochim Biophys Acta       Date:  2007-06-28

2.  Standardization of complex biologically derived spectrochemical datasets.

Authors:  Camilo L M Morais; Maria Paraskevaidi; Li Cui; Nigel J Fullwood; Martin Isabelle; Kássio M G Lima; Pierre L Martin-Hirsch; Hari Sreedhar; Júlio Trevisan; Michael J Walsh; Dayi Zhang; Yong-Guan Zhu; Francis L Martin
Journal:  Nat Protoc       Date:  2019-04-05       Impact factor: 13.491

3.  Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis.

Authors:  Janne Estill; Cindy Aubrière; Matthias Egger; Leigh Johnson; Robin Wood; Daniela Garone; Thomas Gsponer; Gilles Wandeler; Andrew Boulle; Mary-Ann Davies; Timothy B Hallett; Olivia Keiser
Journal:  AIDS       Date:  2012-07-17       Impact factor: 4.177

Review 4.  Tutorial: multivariate classification for vibrational spectroscopy in biological samples.

Authors:  Camilo L M Morais; Kássio M G Lima; Maneesh Singh; Francis L Martin
Journal:  Nat Protoc       Date:  2020-06-17       Impact factor: 13.491

5.  Spectroscopic characterization of human immunodeficiency virus type-1-infected plasma by principal component analysis and soft independent modeling of class analogy of visible and near-infrared spectra.

Authors:  Mirza K Bahmani; Ayyoob Khosravi; Ramin Miri; Yukie Iwabu; Kazuyoshi Ikuta; Akikazu Sakudo
Journal:  Mol Med Rep       Date:  2009 Sep-Oct       Impact factor: 2.952

6.  Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care.

Authors:  Gary Marks; Lytt I Gardner; Charles E Rose; Anne Zinski; Richard D Moore; Susan Holman; Allan E Rodriguez; Meg Sullivan; Thomas P Giordano
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

7.  Mid-ATR-FTIR spectroscopic profiling of HIV/AIDS sera for novel systems diagnostics in global health.

Authors:  Lungile Sitole; Francois Steffens; Tjaart P J Krüger; Debra Meyer
Journal:  OMICS       Date:  2014-06-17

Review 8.  HIV infection.

Authors:  Steven G Deeks; Julie Overbaugh; Andrew Phillips; Susan Buchbinder
Journal:  Nat Rev Dis Primers       Date:  2015-10-01       Impact factor: 52.329

9.  Spectrochemical analysis in blood plasma combined with subsequent chemometrics for fibromyalgia detection.

Authors:  João Octávio Sales Passos; Marcelo Victor Dos Santos Alves; Camilo L M Morais; Francis L Martin; Antônio Felipe Cavalcante; Telma Maria Araújo Moura Lemos; Shayanne Moura; Daniel L D Freitas; João Vitor Medeiros Mariz; Jean Lucas Carvalho; Kássio M G Lima; Rodrigo Pegado
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

Review 10.  Spectroscopy with computational analysis in virological studies: A decade (2006-2016).

Authors:  Marfran C D Santos; Camilo L M Morais; Yasmin M Nascimento; Josélio M G Araujo; Kássio M G Lima
Journal:  Trends Analyt Chem       Date:  2017-09-21       Impact factor: 12.296

View more
  3 in total

1.  Near-infrared spectroscopy of blood plasma with chemometrics towards HIV discrimination during pregnancy.

Authors:  Daniel L D Freitas; Ana F S Peres; Lidiane G Silva; João V M Mariz; Marcos G Santos; Rayanne S P Morais; Camilo L M Morais; Francis L Martin; Daniel A V Pascoal; Juliana D de A S Camargo; Janaina C O Crispim; Kassio M G Lima
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

Review 2.  Fourier Transform Infrared (FTIR) Spectroscopy to Analyse Human Blood over the Last 20 Years: A Review towards Lab-on-a-Chip Devices.

Authors:  Ahmed Fadlelmoula; Diana Pinho; Vitor Hugo Carvalho; Susana O Catarino; Graça Minas
Journal:  Micromachines (Basel)       Date:  2022-01-26       Impact factor: 2.891

3.  Specific intracellular signature of SARS-CoV-2 infection using confocal Raman microscopy.

Authors:  Hamideh Salehi; Anuradha Ramoji; Said Mougari; Peggy Merida; Aymeric Neyret; Jurgen Popp; Branka Horvat; Delphine Muriaux; Frederic Cuisinier
Journal:  Commun Chem       Date:  2022-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.